The risk of fraud is also very real, especially in an industry that already faces privacy and compliance challenges, one expert says.
There's a reason pharma lags on the programmatic adoption curve: It's a heavily regulated industry, and there are concerns around privacy.
A new survey found that U.S. pharma marketers prefer using social media and mobile apps to reach healthcare providers.
How pharma distributes information to doctors is changing as rapidly as how doctors prefer to receive and process such information
Judges loved the strategy and the comprehensive suite of support available across platforms for the Quitter's Circle.
Judges thought the Cooties Catcher campaign for Purell to help schoolchildren keep their hands clean was brilliant, innovative, and exceptionally well executed.
In the A Thousand Words About NTM campaign, real NTM patients were paired with artists who created original pieces that communicate patients' difficult journey to diagnosis.
Learn six ways to apply this data to new types of highly efficient and effective digital strategies.
Join this live webinar to hear how AbbVie standardized their digital content creation process across brands, accelerating production cycles, eliminating sales re-training, and empowering sales representatives with customized and compliant content.
It's a common refrain in healthcare and among patients, providers, and payers: Despite massive investment, no one has figured out how to change human behavior.
The FTC asks for more info about Pfizer-Allergan deal; the FDA loosens guidelines for abortion-inducing drug; startup to deliver Truvada through an app
Viscira, a digital marketing agency, works with GlaxoSmithKline, Merck, and Genentech, among other life-sciences companies.
Here's my biggest gripe: Innovation teams should be driving innovation for their particular business, not just for marketing and communications.
Perfectionists in the world of pharma marketing can no longer rely on the status quo, given current threats to traditional commercial models and the rise of digital HCP engagement.
The agency announced a partnership with Vencore Health Analytics to help pair rare disease patients with drugmakers.
The Silicon Valley gadget guru who helped define the beyond-the-pill era will talk about embedding nontraditional capabilities into biopharma business models.
They will attempt to develop a new industry standard for digital advertising viewability, a much debated topic that has vexed the broader advertising industry.
Part of LinkedIn's appeal lies in the high level of engagement of its members and the potential for precise targeting of content and talent searches.
Fitbit faces allegations of inaccurate heart monitoring; Viiv Healthcare to collaborate with Janssen; Guardant Health raises funding for its cancer blood tests
Here are the 40 executives, investors, entrepreneurs, designers and thinkers who are ushering the industry into its new technological golden era.
An initial list of consumer health tech deemed essential by MIT and Harvard doctors is short on pharma-backed apps or services.
The agency will team up with Tsinghua Institute of Health Communication on study on how consumers interact with healthcare content.
A nonprofit institute will soon start producing consumer reviews of digital health tools that have been vetted by Harvard clinicians.
The company "embraces" adverse-event reporting and knows not to expect monetary ROI from unbranded initiatives, says its US-based social media lead.
The deal combines two of Merck's wholly owned subsidiaries.
Part of the challenge for drugmakers, medical-device makers and healthcare providers is finding the right digital talent and advocating for cultural changes within their organizations.
Microsoft's second-generation fitness tracker comes outfitted with new sensors aimed at better capturing user activity.
The drugmaker launched its first YouTube channel as it kicked off the campaign.
Teva acquires sensor-based inhaler; EU conditionally approves Amgen's cancer drug, Blincyto; Novartis CEO says targeted therapies may reduce unnecessary US healthcare spending
In order to reach consumers, hospitals must rethink their old ways of marketing outreach.
- BI and Lilly face a new challenge: how to market a diabetes drug to cardiologists
- Mylan CEO defends EpiPen strategy, questions pricing model in the U.S.
- Five things for pharma marketers to know: Wednesday, December 7, 2016
- Five things for pharma marketers to know: Monday, December 5, 2016
- Matt Brown leaves Guidemark Health after merger falls through
- Omnicom merges AgencyRx, Flashpoint and three other agencies to form DDB Health
- No free lunch for docs: Sponsored meals linked to more prescriptions
- Non-profit behind Free Killer Tan wants parents to practice sun safety
- Allergan draws on A-list celebs to drive engagement
- Women in senior industry roles improve connections with patients, execs say